| A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer KP Ng, AM Hillmer, CTH Chuah, WC Juan, TK Ko, ASM Teo, ... Nature medicine 18 (4), 521-528, 2012 | 684 | 2012 |
| Non–small cell lung cancer: histopathologic correlates for texture parameters at CT B Ganeshan, V Goh, HC Mandeville, QS Ng, PJ Hoskin, KA Miles Radiology 266 (1), 326-336, 2013 | 500 | 2013 |
| Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised … M Smith, C Parker, F Saad, K Miller, B Tombal, QS Ng, M Boegemann, ... The Lancet Oncology 20 (3), 408-419, 2019 | 413 | 2019 |
| Concurrent chemo-radiation with or without induction gemcitabine, carboplatin, and paclitaxel: a randomized, phase 2/3 trial in locally advanced nasopharyngeal carcinoma T Tan, WT Lim, KW Fong, SL Cheah, YL Soong, MK Ang, QS Ng, D Tan, ... International Journal of Radiation Oncology* Biology* Physics 91 (5), 952-960, 2015 | 238 | 2015 |
| Lung Cancer Perfusion at Multi–Detector Row CT: Reproducibility of Whole Tumor Quantitative Measurements1 QS Ng, V Goh, H Fichte, E Klotz, P Fernie, MI Saunders, PJ Hoskin, ... Radiology 239 (2), 547-553, 2006 | 196 | 2006 |
| Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer GGY Lai, TH Lim, J Lim, PJR Liew, XL Kwang, R Nahar, ZW Aung, ... Journal of clinical oncology 37 (11), 876-884, 2019 | 128 | 2019 |
| Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: a phase I study QS Ng, V Goh, J Milner, MR Stratford, LK Folkes, GM Tozer, MI Saunders, ... The lancet oncology 8 (2), 111-118, 2007 | 124 | 2007 |
| Pembrolizumab-induced Stevens–Johnson syndrome in non-melanoma patients S Saw, HY Lee, QS Ng European Journal of Cancer 81, 237-239, 2017 | 117 | 2017 |
| A Phase II study of pazopanib in Asian patients with recurrent/metastatic nasopharyngeal carcinoma WT Lim, QS Ng, P Ivy, SS Leong, O Singh, B Chowbay, F Gao, CH Thng, ... Clinical cancer research 17 (16), 5481-5489, 2011 | 117 | 2011 |
| Acute tumor vascular effects following fractionated radiotherapy in human lung cancer: in vivo whole tumor assessment using volumetric perfusion computed tomography QS Ng, V Goh, J Milner, AR Padhani, MI Saunders, PJ Hoskin International Journal of Radiation Oncology* Biology* Physics 67 (2), 417-424, 2007 | 105 | 2007 |
| Quantitative assessment of lung cancer perfusion using MDCT: does measurement reproducibility improve with greater tumor volume coverage? QS Ng, V Goh, E Klotz, H Fichte, MI Saunders, PJ Hoskin, AR Padhani American Journal of Roentgenology 187 (4), 1079-1084, 2006 | 99 | 2006 |
| Advances in systemic treatment for nasopharyngeal carcinoma WL Tan, EH Tan, DWT Lim, QS Ng, DSW Tan, A Jain, MK Ang Chinese clinical oncology 5 (2), 21-21, 2016 | 92 | 2016 |
| Tumor antivascular effects of radiotherapy combined with combretastatin a4 phosphate in human non–small-cell lung cancer QS Ng, V Goh, D Carnell, K Meer, AR Padhani, MI Saunders, PJ Hoskin International Journal of Radiation Oncology* Biology* Physics 67 (5), 1375-1380, 2007 | 87 | 2007 |
| Phase Ib trial of radiotherapy in combination with combretastatin-A4-phosphate in patients with non-small-cell lung cancer, prostate adenocarcinoma, and squamous cell carcinoma … QS Ng, H Mandeville, V Goh, R Alonzi, J Milner, D Carnell, K Meer, ... Annals of oncology 23 (1), 231-237, 2012 | 72 | 2012 |
| EGFR mutation subtypes influence survival outcomes following first-line gefitinib therapy in advanced Asian NSCLC patients N Sutiman, SW Tan, EH Tan, WT Lim, R Kanesvaran, QS Ng, A Jain, ... Journal of Thoracic Oncology 12 (3), 529-538, 2017 | 71 | 2017 |
| A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC) WM Tai, WP Yong, C Lim, LS Low, CK Tham, TS Koh, QS Ng, WW Wang, ... Annals of Oncology 27 (12), 2210-2215, 2016 | 62 | 2016 |
| Intertumor heterogeneity of non‐small‐cell lung carcinomas revealed by multiplexed mutation profiling and integrative genomics DSW Tan, S Camilleri‐Broët, EH Tan, M Alifano, WT Lim, A Bobbio, ... International journal of cancer 135 (5), 1092-1100, 2014 | 59 | 2014 |
| Computed tomography perfusion imaging for therapeutic assessment: has it come of age as a biomarker in oncology? V Goh, QS Ng, K Miles Investigative radiology 47 (1), 2-4, 2012 | 58 | 2012 |
| Assessment of psychological distress among Asian adolescents and young adults (AYA) cancer patients using the distress thermometer: a prospective, longitudinal study A Chan, E Poon, WL Goh, Y Gan, CJ Tan, K Yeo, A Chua, M Chee, ... Supportive Care in Cancer 26, 3257-3266, 2018 | 54 | 2018 |
| Operable non–small cell lung cancer: correlation of volumetric helical dynamic contrast-enhanced CT parameters with immunohistochemical markers of tumor hypoxia HC Mandeville, QS Ng, FM Daley, PR Barber, G Pierce, J Finch, M Burke, ... Radiology 264 (2), 581-589, 2012 | 54 | 2012 |
